Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
181–216
Headlines
591
Sources here
3
Companies here
21
Current section Brazil Healthcare news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Arrow Exploration confirms four zones at Icaco 3, opens up ~10 new drilling locations

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) CEO Marshall Abbott tells Proactive's Stephen Gunnion that the Icaco 3 well has confirmed up to four hydrocarbon-bearing zones in the Icaco extension of the Tapir Block in Colombia, opening almost 10 additional development locations across the Ubaque, …

ABTT34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks -21.9% ABTT34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

2 Stocks I Think Are Hands-Down Better Picks Than SpaceX Right Now

Space Exploration Technologies (NASDAQ: SPCX) has been perhaps the most talked-about stock on Wall Street since it completed the largest IPO ever in mid-June. Opinions on the company's prospects are divided. Some see an innovative company that has already disrupted the space travel industry …

LILY34 mentioned
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Cardinal Health Q4 Earnings Call Highlights

Key Points Interested in Cardinal Health, Inc.? Here are five stocks we like better. Cardinal Health delivered strong fiscal fourth-quarter results: Revenue rose 6% to $63.7 billion, operating income increased 30% to $935 million, and adjusted EPS climbed 40% to $2.91. Results included a …

C1AH34 main company M1CK34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

How Much Did Immunology Drugs Contribute to AbbVie's Q2 Performance?

AbbVie ABBV announced encouraging second-quarter 2026 results last month, which beat expectations for both earnings and sales. A significant portion of this growth came from the continued strength of its two blockbuster immunology medications, Skyrizi and Rinvoq, which together accounted for more than 47% …

ABBV34 main company LILY34 mentioned JNJB34 mentioned
Sharemaestro market context Trend signal active 52 weeks +14.4% ABBV34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

BridgeBio Q2 Earnings Miss, Revenues Beat as Attruby Sales Surge

BridgeBio Pharma BBIO reported a second-quarter 2026 loss of 78 cents per share, wider than the Zacks Consensus Estimate of a loss of 64 cents. Despite the miss, the figure improved compared to the year-ago loss of 95 cents. Revenues surged 120% year over …

PFIZ34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +4.1% PFIZ34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

IDEXX (IDXX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Officer - Andrew Emerson Vice President, Investor Relations - John Ravis Full Conference Call Transcript Operator: Good morning, …

I1DX34 main company
Sharemaestro market context Price above Trend Line 52 weeks -13.6% · Next-week setup negative 31.9% I1DX34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up

Cardinal Health, Inc. CAH reported fourth-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.91, beating the Zacks Consensus Estimate by 20.3%. The bottom line improved 40% year over year, aided by higher operating earnings, IEEPA tariff refunds, a lower tax rate and a …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

argenx (ENXTBR:ARGX) Draws Fresh Valuation Debate, Is The Stock Overvalued Or Undervalued?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Recent share performance and business profile Without a single clear news event driving headlines, …

A1RG34 mentioned
Sharemaestro market context Trend signal active 52 weeks +28.7% · Next-week setup negative 39.7% A1RG34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Pfizer (PFE) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 11:00 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Albert Bourla Chief Financial Officer - David Denton Incoming Interim Chief Financial Officer and Executive Vice President - Cecile Guegan Chief Scientific …

PFIZ34 main company
Sharemaestro market context Price above Trend Line 52 weeks +4.1% PFIZ34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Stocks Finish Lower as Soaring Crude Prices Spur Inflation Fears

The S&P 500 Index ($SPX) (SPY) closed down -0.06% on Monday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.11%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.34%. September E-mini S&P futures (ESU26) fell -0.07%, and September E-mini Nasdaq futures (NQU26) …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

European equities traded in the US as American depositary receipts were tracking higher late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have …

N1VO34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks -13.6% N1VO34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised

RadNet, Inc. RDNT reported second-quarter 2026 adjusted earnings of 29 cents per share, down 14.7% year over year but ahead of the Zacks Consensus Estimate of 18 cents by 61.1%. GAAP EPS was 10 cents compared with 19 cents in the prior-year period. Growth …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Lilly Takes Its Weight-Loss Pill Battle Overseas

This article first appeared on GuruFocus. Eli Lilly and Co. (LLY, Financials), the developer of Foundayo and Zepbound, has received U.K. approval for Foundayo, the first approval for the weight-loss medication outside of the U.S. The The strategy pits Lilly directly against Novo Nordisk's …

LILY34 main company N1VO34 mentioned
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Tecan Group AG (TCHBF) (H1 2026) Earnings Call Highlights: Strategic Progress and Market ...

This article first appeared on GuruFocus. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Tecan Group AG (TCHBF) delivered solid above-market growth in both segments, with group sales up …

N1VS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +20.2% N1VS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Zacks Analyst Blog Highlights Illumina, Qnity Electronics and nVent Electric

For Immediate Release Chicago, IL – August 11, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in …

I1LM34 main company
Sharemaestro market context Trend signal active 52 weeks +78.4% I1LM34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Existing Home Sales Data in Focus

Pre-market futures are correcting Monday's slight selloff at this hour; ultimately, as we had said in this space yesterday, we don't expect much movement either direction until inflation reports begin to hit the tape Wednesday morning with the Consumer Price Index (CPI) Inflation Rate. …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Small Biz Index, Existing Home Sales & More Earnings

Tuesday, August 11th, 2026 Pre-market futures are correcting Monday's slight selloff at this hour; ultimately, as we had said in this space yesterday, we don't expect much movement either direction until inflation reports begin to hit the tape Wednesday morning with the Consumer Price …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Why Cardinal Health Stock Is Heading for a Record After Mixed Earnings

Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds. Continue Reading

C1AH34 main company
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Do Options Traders Know Something About AstraZeneca Stock We Don't?

Investors in AstraZeneca PLC AZN need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 15, 2027 $115.00 Call had some of the highest implied volatility of all equity options today. What is …

A1ZN34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks -2.6% · Next-week setup positive 58.2% A1ZN34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth

Key Points Interested in AdaptHealth Corp.? Here are five stocks we like better. AdaptHealth is selling its roughly $600 million diabetes business to Cardinal Health and exiting certain e-commerce and drop-ship operations to simplify the company and focus on sleep, respiratory and home medical …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Hedge Funds are Bullish on AstraZeneca PLC (AZN)

AstraZeneca PLC (NYSE:AZN) topped second-quarter profit expectations, with core earnings per share of $2.63 versus the $2.48 analysts expected. The firm reiterated its target of $80 billion in annual revenue by 2030. However, the quarter also brought fresh pipeline trouble: its rare disease drug …

A1ZN34 main company
Sharemaestro market context Price below Trend Line 52 weeks -2.6% · Next-week setup positive 58.2% A1ZN34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

MRK Stock Up 5.6% in a Month as Estimates Fall: Buy, Hold or Sell?

Merck's MRK stock is up 5.6% in a month. The key reason for the increase was the strong second-quarter 2026 performance. Merck beat estimates for both earnings and sales in the second quarter. Revenues in the second quarter increased 5% to $16.61 billion as …

MRCK34 mentioned A1ZN34 mentioned M1RN34 mentioned
Sharemaestro market context Trend signal active 52 weeks +46.5% MRCK34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

These stocks have some of Wall Street’s lowest short interest

[short sale] abluecup Stocks including Apple, Alphabet, Exxon Mobil, and JPMorgan are among the companies with relatively low short interest, according to a screen of stocks with market capitalizations above $2B. The screen includes stocks with short interest between 1% and 2% of shares …

LILY34 mentioned
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls

Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 …

C1NC34 mentioned
Sharemaestro market context Trend signal active 52 weeks +117.4% C1NC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Cardinal Health (CAH) reported revenue of $63.67 billion, up 5.8% over the same period last year. EPS came in at $2.91, compared to $2.08 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

C1AH34 main company
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

S&P 500 Medical Stocks: Three Trade Near Buy Points; One Rallies Despite Mixed Results

S&P 500 drug distributor Cardinal Health easily topped fiscal fourth-quarter earnings forecasts despite a revenue shortfall. Rival McKesson, which whipsawed after its earnings report last week, has climbed back near a buy point. Cencora, another big S&P 500 drug distributor, also is near a …

M1CK34 mentioned C1AH34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +15.8% M1CK34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?

Johnson & Johnson JNJ stock has been trading above both its 50-day and 200-day simple moving averages (SMAs) since mid-June. Trading above the 200-day SMA indicates that the stock's longer-term trend has turned positive, while staying above the 50-day SMA suggests that shorter-term momentum …

LILY34 mentioned JNJB34 mentioned
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run

Quick Read ISRG is down 31% YTD, but its razor-and-razorblade model now delivers 85% recurring revenue across a fleet of 11,710 da Vinci systems. MDT's Hugo and JNJ's Ottava remain early or pre-commercial, leaving ISRG's $1.73 billion quarterly instruments-and-accessories stream with no real soft-tissue …

MDTC34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks -10.3% MDTC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Diseases"

A Milestone 20th Anniversary Edition Recognizing Excellence in Medical Science and Patient Care NEW YORK, Aug. 11, 2026 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the nominees for the 2026 Prix Galien USA …

MRCK34 mentioned BIIB34 mentioned
Sharemaestro market context Trend signal active 52 weeks +46.5% MRCK34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Nucleai Advances AI-Powered Tissue Intelligence Through Large-Scale Oncology ADC Collaboration

Collaboration demonstrates how AI-powered Tissue Intelligence is transforming biomarker discovery, translational research, and precision oncology development. TEL AVIV, Israel, August 11, 2026--(BUSINESS WIRE)--Nucleai, a leader in AI-powered Tissue Intelligence, which integrates multimodal tissue image analysis with clinical data to deliver translational insights, today announced …

GILD34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks +8.3% GILD34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Google Health's technology to create a more comprehensive view of personal health Partnership includes a large-scale research study to better inform artificial intelligence (AI) coaching available in the Google Health app and future …

ABTT34 main company
Sharemaestro market context Price above Trend Line 52 weeks -21.9% ABTT34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Cardinal Health Ticks Higher Despite Medical Wholesaler's Mixed Quarter

Cardinal Health stock rose slightly early Tuesday on better-than-expected fiscal fourth-quarter earnings, but sales missed. Continue Reading

C1AH34 main company
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?

The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE:NVO) filed a lawsuit in U.S. District Court in New Jersey against Eli Lilly and Company (NYSE:LLY) on July 21, accusing its primary rival …

LILY34 main company N1VO34 mentioned
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Cloud AI Today - Novo Nordisk Partners With AWS For AI-Driven Drug Discovery

Novo Nordisk has entered a strategic partnership with Amazon Web Services (AWS) to enhance drug discovery using artificial intelligence and cloud technologies. This collaboration includes establishing a co-innovation hub in London, which brings together AWS engineers, AI specialists, and Novo Nordisk's research and development …

N1VO34 main company
Sharemaestro market context Price above Trend Line 52 weeks -13.6% N1VO34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), two companies forever linked by their historic COVID-19 vaccine partnership, reported Q2 2026 earnings alongside major strategic announcements. While the European Commission authorized their updated XFG-adapted COVID-19 vaccine on July 29, the two partners are traveling down …

PFIZ34 main company B1NT34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +4.1% PFIZ34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine

Olink™ Explore HT analysis of approximately 5,500 research samples completed, with data now available Key Facts Collaboration: Thermo Fisher Scientific and The Michael J. Fox Foundation expanded the Parkinson's Precision Medicine Initiative (PPMI) proteomic data resource. Scale: Approximately 5,500 research samples were analyzed using …

TMOS34 main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context